Index Ventures exits X01

By Iris Dorbian — 8 months ago

According to a blog post on its site, Index Ventures has sold X01 Ltd to Janssen Pharmaceuticals Inc, a Johnson and Johnson subsidiary. No financial terms were disclosed. X01 is a cardiovascular drug startup. To read the announcement, visit here.